Analysts show less optimism for Teradata after recent earnings, with lowered revenue predictions and a slight decrease in EPS expectations. They suggest potential business challenges for Teradata, expecting slower growth than the industry. The consensus price target dropped significantly, indicating a reduced estimate of Teradata's future valuation.
Teradata's Q4 results and 2024 guidance may have caused an overreaction in the market, potentially creating a buying opportunity. The company's CFO reassures that missed deals are expected to materialize in 2024, not indicating a long-term issue. The company aims to achieve over $1 billion of cloud ARR by 2025 end.
The quarter's results were satisfactory but the company's guidance for 2024 ARR, revenue, and non-GAAP EPS were all below expectations, causing an 11.5% drop in the stock price. The company's strong free cash flow provides it with plenty of cash to reinvest in its business.
Confluent's revenue growth outpaced peers but its full-year guidance was weakest. Teradata's quarter was decent, but missed Wall Street's income and cash flow estimates. C3.ai's quarter was weak with disappointing next quarter revenue guidance. Elastic had a mixed quarter with a decent revenue beat but slowing customer growth.
Teradata potentially falling below its cloud ARR guidance due to a delayed significant deal has negatively impacted share prices, pointing to market sensitivity to financial forecasts.
Despite recent share price dip, Teradata's long-term stock performance remains positive. Potential investors should evaluate the discrepancy between historical earnings, revenue and share price. The one-year TSR improvement over the five-year TSR may indicate business momentum.
Teradata's improving ROCE suggests efficient investment of capital and manifests a promising trend. The current stock performance suggests potential underestimation of Teradata's promising growth by investors, marking it a candidate for further research notwithstanding identified risks.
天睿公司股票討論區
2007年上市,主要做雲數據分析業務,51%的市場在美國,當前價格48.73。
5年來營收總體萎縮,營業利潤2021年靠成本費用的控制一度達到2.3億,2022年迅速跌到1.2億,淨利潤則受所得稅影響在2020和2021年均有較高利潤,2022年跌回0.33億。
2023前3季度營收增長2.5%,營業利潤增長29.9%,淨利潤達到0.69億。
目前市盈率157.3,市盈率TTM81.3,即使按2021年1.5億利潤高點計算,市盈率也達到了32,對於營收增長失速的股票來說估值缺乏吸引力。
暫無評論